BIOSANTE PHARMACEUTICALS INC's ticker is BPAX and the CUSIP is 09065V302. A total of 1 filers reported holding BIOSANTE PHARMACEUTICALS INC in Q4 2011. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2013 | $15,000 | -28.6% | 15,052 | -16.3% | 0.00% | -33.3% |
| Q1 2013 | $21,000 | -4.5% | 17,980 | 0.0% | 0.01% | -14.3% |
| Q4 2012 | $22,000 | -35.3% | 17,980 | 0.0% | 0.01% | -41.7% |
| Q3 2012 | $34,000 | -26.1% | 17,980 | 0.0% | 0.01% | -29.4% |
| Q2 2012 | $46,000 | -37.0% | 17,980 | -83.3% | 0.02% | -39.3% |
| Q1 2012 | $73,000 | +35.2% | 107,908 | 0.0% | 0.03% | +27.3% |
| Q4 2011 | $54,000 | -87.2% | 107,908 | -41.5% | 0.02% | -88.9% |
| Q3 2011 | $421,000 | -17.0% | 184,505 | 0.0% | 0.20% | -26.9% |
| Q2 2011 | $507,000 | +38.9% | 184,505 | +0.0% | 0.27% | +41.9% |
| Q1 2011 | $365,000 | – | 184,500 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 2,244,663 | $2,545,000 | 1.84% |
| Zuckerman Investment Group, LLC | 15,052 | $15,000 | 0.00% |
| Saiers Capital, LLC | 216,667 | $11,000 | 0.00% |
| LifePlan Financial Group, Inc | 5 | $0 | 0.00% |
| KNIGHT CAPITAL GROUP LLC | 13,385 | $13,000 | 0.00% |
| D.A. DAVIDSON & CO. | 166 | $0 | 0.00% |
| BLACKROCK ADVISORS LLC | 8,984 | $9,000 | 0.00% |
| UBS AG | 3,000 | $3,000 | 0.00% |
| UBS AG | 3,600 | $4,000 | 0.00% |
| UBS AG | 23,825 | $24,000 | 0.00% |